Research
Molecular
Tirzepatide is a GIP receptor and GLP-1 receptor agonist.
Understanding the mechanism can help in predicting the drug's effects and potential interactions.
StrongSupportsmedium confidence
Tirzepatide is a Glucose-dependent Insulinotropic Polypeptide (GIP) receptor and Glucagon-Like Peptide-1 (GLP-1) receptor agonist.
Why this rating
The abstract provides a clear description of the drug's mechanism.
Source
Drug Review: Tirzepatide
Juman Alsaab · Pharmacology Toxicology and Biomedical Reports · 2023
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →